Kook Hwan Oh

Suggest Changes
Learn More
AIMS This multicentre, randomized, double-blind study investigated the efficacy and safety of gemigliptin in Korean type 2 diabetes mellitus (T2DM) patients with moderate to severe renal impairment(More)